These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1978481)

  • 1. Remoxipride versus thioridazine in elderly psychotic patients.
    Phanjoo AL; Link C
    Acta Psychiatr Scand Suppl; 1990; 358():181-5. PubMed ID: 1978481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
    McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Herrington RN; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
    Acta Psychiatr Scand Suppl; 1990; 358():136-7. PubMed ID: 1978473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Lindström LH; Wieselgren IM; Struwe G; Kristjansson E; Akselson S; Arthur H; Andersen T; Lindgren S; Norman O; Naimell L
    Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia.
    Keks N; McGrath J; Lambert T; Catts S; Vaddadi K; Burrows G; Varghese F; George T; Hustig H; Burnett P
    Acta Psychiatr Scand; 1994 Nov; 90(5):358-65. PubMed ID: 7872041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
    Ahlfors UG; Rimön R; Appelberg B; Hagert U; Harma P; Katila H; Mahlanen A; Mehtonen OP; Naukkarinen H; Outakoski J
    Acta Psychiatr Scand Suppl; 1990; 358():99-103. PubMed ID: 1978501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
    McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
    Acta Psychiatr Scand; 1988 Jul; 78(1):49-56. PubMed ID: 2972165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
    Laux G; Klieser E; Schröder HG; Dittmann V; Unterweger B; Schubert H; König P; Schöny HW; Bunse J; Beckmann H
    Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
    Deo R; Soni S; Rastogi SC; Levine S; Plant I; Edwards JG; Mitchell M; Chanas A
    Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Andersen J; Kørner A; Ostergaard P; Fensbo C; Birket-Smith M; Thiesen S; Hansen NR; Fogh M; Kristensen M; Møller-Nielsen EM
    Acta Psychiatr Scand Suppl; 1990; 358():104-7. PubMed ID: 1978467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
    Hebenstreit GF; Laux G; Schubert H; Beckmann H; Amman J; Bunse J; Eikmeier G; Geretsegger C; Kanitz RD; Kanzow WT
    Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
    Mendlewicz J; de Bleeker E; Cosyns P; Deleu G; Lotstra F; Masson A; Mertens C; Parent M; Peuskens J; Suy E
    Acta Psychiatr Scand Suppl; 1990; 358():138-41. PubMed ID: 1978474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
    den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
    Acta Psychiatr Scand Suppl; 1990; 358():108-10. PubMed ID: 1978468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
    Chouinard G
    Acta Psychiatr Scand Suppl; 1990; 358():111-9. PubMed ID: 1978469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol.
    Patris M; Agussol P; Alby JM; Brion S; Burnat G; Castelnau D; Deluermoz S; Dufour H; Ferreri M; Goudemand M
    Acta Psychiatr Scand Suppl; 1990; 358():78-82. PubMed ID: 1978497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression.
    Stabl M; Kasas A; Blajev B; Bajetta G; Zöchling R; Holsboer-Trachsler E; Realini R; Schäublin-Loidl M
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):41S-45S. PubMed ID: 7593730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
    Pflug B; Bartels M; Bauer H; Bunse J; Gallhofer B; Haas S; Kanzow WT; Klieser E; Küfferle B; Stein D
    Acta Psychiatr Scand Suppl; 1990; 358():142-6. PubMed ID: 1978475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia.
    King DJ; Blomqvist M; Cooper SJ; Doherty MM; Mitchell MJ; Montgomery RC
    Psychopharmacology (Berl); 1992; 107(2-3):175-9. PubMed ID: 1352050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early phase II clinical trial of remoxipride in treatment of schizophrenia with measurements of prolactin and neuroleptic activity.
    Chouinard G
    J Clin Psychopharmacol; 1987 Jun; 7(3):159-64. PubMed ID: 2885345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration of remoxipride in relation to antipsychotic effect and adverse symptoms. The Canadian Remoxipride Study Group.
    Jostell KG; Lapierre YD
    Acta Psychiatr Scand Suppl; 1990; 358():48-50. PubMed ID: 1978488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiences of long-term treatment with remoxipride: efficacy and tolerability.
    Wålinder J; Holm AC
    Acta Psychiatr Scand Suppl; 1990; 358():158-63. PubMed ID: 1978477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.